Top Markets
Coin of the day
Caregen Co., Ltd. Caregen Co., Ltd.

Caregen Co., Ltd.

214370
Rank in Stocks #6970
Caregen Co., Ltd. is primarily involved in the creation and development of... Caregen Co., Ltd. is primarily involved in the creation and development of biomimetic peptides. The company operates through distinct business segments, each catering to specific markets. Its Professional Therapy division engineers medical devices utilizing functional peptides and sophisticated sustained-release technology. Through its Cosmeceutical line, Caregen offers a variety of products for skin and hair care, including solutions for whitening, anti-inflammatory purposes, and those mimicking botulinum toxin functions. The Health Functional Food division provides dietary supplements specifically designed for blood control. Additionally, the Raw Material segment supplies essential peptide growth factors. Founded on August 17, 2001, the firm is headquartered in Anyang-si, South Korea.
Share Price
$36.30
Market Cap
$1.77B
Change (1 day)
-1.32%
Change (1 year)
-5.99%
Country
KR
Trade Caregen Co., Ltd. (214370)
P/E ratio for Caregen Co., Ltd. (214370)
P/E ratio as of 2026 TTM: 0
According to Caregen Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Caregen Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.